ATE407665T1 - Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken - Google Patents

Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken

Info

Publication number
ATE407665T1
ATE407665T1 AT03747680T AT03747680T ATE407665T1 AT E407665 T1 ATE407665 T1 AT E407665T1 AT 03747680 T AT03747680 T AT 03747680T AT 03747680 T AT03747680 T AT 03747680T AT E407665 T1 ATE407665 T1 AT E407665T1
Authority
AT
Austria
Prior art keywords
shell
release
dosage form
core
diffusion
Prior art date
Application number
AT03747680T
Other languages
English (en)
Inventor
Chen-Chao Wang
Jaedeok Yoo
Esteban Bornancini
Willie Roach
Monica Motwani
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE407665T1 publication Critical patent/ATE407665T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C64/00—Additive manufacturing, i.e. manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3D printing, stereolithography or selective laser sintering
    • B29C64/10—Processes of additive manufacturing
    • B29C64/141—Processes of additive manufacturing using only solid materials
    • B29C64/153—Processes of additive manufacturing using only solid materials using layers of powder being selectively joined, e.g. by selective laser sintering or melting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y70/00—Materials specially adapted for additive manufacturing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00—Products made by additive manufacturing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03747680T 2002-05-06 2003-05-06 Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken ATE407665T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37844902P 2002-05-06 2002-05-06
US42509402P 2002-11-08 2002-11-08

Publications (1)

Publication Number Publication Date
ATE407665T1 true ATE407665T1 (de) 2008-09-15

Family

ID=29406838

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03747680T ATE407665T1 (de) 2002-05-06 2003-05-06 Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken

Country Status (9)

Country Link
US (2) US8088415B2 (de)
EP (1) EP1503741B1 (de)
JP (1) JP5041663B2 (de)
AT (1) ATE407665T1 (de)
AU (1) AU2003232078A1 (de)
CA (1) CA2483028C (de)
DE (1) DE60323482D1 (de)
ES (1) ES2316791T3 (de)
WO (1) WO2003092633A2 (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60323482D1 (de) 2002-05-06 2008-10-23 Massachusetts Inst Technology Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken
KR20060092255A (ko) * 2003-09-26 2006-08-22 알자 코포레이션 고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
US8101244B2 (en) * 2004-06-09 2012-01-24 Smithkline Beecham Corporation Apparatus and method for producing or processing a product or sample
TWI547431B (zh) * 2004-06-09 2016-09-01 史密斯克萊美占公司 生產藥物之裝置及方法
US20060002594A1 (en) * 2004-06-09 2006-01-05 Clarke Allan J Method for producing a pharmaceutical product
JPWO2006004069A1 (ja) * 2004-07-01 2008-04-24 日本碍子株式会社 微小カプセルおよびその製造方法
WO2008110337A2 (en) * 2007-03-09 2008-09-18 Synthon B.V. Pharmaceutical composition of quetiapine fumarate
US8357395B2 (en) * 2007-12-21 2013-01-22 Mcneil-Ppc, Inc. Manufacture of tablet
CN101716162B (zh) * 2009-11-26 2012-11-14 扬州中宝制药有限公司 一种氨茶碱缓释胶囊及其制备方法
US8251837B2 (en) * 2010-08-11 2012-08-28 Nike, Inc. Floating golf ball
AU2011342893A1 (en) 2010-12-13 2013-05-02 Purdue Pharma L.P. Controlled release dosage forms
US9381154B2 (en) * 2011-06-09 2016-07-05 Xerox Corporation Direct inkjet fabrication of drug delivery devices
CN104640686B (zh) 2012-09-05 2018-01-30 阿普雷奇亚制药公司 三维打印系统和设备组件
US8888480B2 (en) 2012-09-05 2014-11-18 Aprecia Pharmaceuticals Company Three-dimensional printing system and equipment assembly
US20140099351A1 (en) * 2012-10-04 2014-04-10 Axxia Pharmaceuticals, Llc Process for making controlled release medical implant products
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
AU2014228990B2 (en) 2013-03-15 2017-02-02 Aprecia Pharmaceuticals LLC Rapid disperse dosage form containing levetiracetam
EP3033188A4 (de) 2013-08-16 2017-03-22 The Exone Company Dreidimensionale bedruckte metallgussformen und verfahren zur herstellung davon
EP3057729A4 (de) 2013-10-17 2017-10-18 The Exone Company Isostatische heisspressbehälter mit 3d-druck und verfahren zur herstellung davon
EP2875933B1 (de) * 2013-11-25 2019-04-03 MTU Aero Engines GmbH Dokumentation generativer Herstellungsverfahren
SG11201604805XA (en) 2013-12-16 2016-07-28 Massachusetts Inst Technology Fortified micronutrient salt formulations
JP2017507165A (ja) * 2013-12-16 2017-03-16 マサチューセッツ インスティテュート オブ テクノロジー マイクロモールド成形された、または３次元印刷されたパルス放出ワクチン製剤
WO2015100084A1 (en) 2013-12-23 2015-07-02 The Exone Company Method of three-dimensional printing using a multi-component build powder
EP3086920B1 (de) 2013-12-23 2019-07-24 The Exone Company Verfahren und systeme für dreidimensionales drucken mittels mehrerer bindemittelflüssigkeiten
IL232696B (en) * 2014-05-19 2018-08-30 Technion Res & Dev Foundation Compound and method for detecting molecules of interest
WO2015183796A1 (en) 2014-05-29 2015-12-03 The Exone Company Process for making nickel-based superalloy articles by three-dimensional printing
US20170203514A1 (en) 2014-07-17 2017-07-20 The Exone Company Methods and Apparatuses for Curing Three-Dimensional Printed Articles
EP3505163B1 (de) 2014-09-08 2023-01-18 University of Central Lancashire Herstellung von fester darreichungsform
US9844930B2 (en) 2014-11-05 2017-12-19 Xerox Corporation 3D printing of digestible shells for medicaments
ES2832588T3 (es) 2014-12-03 2021-06-10 The Exone Co Proceso para fabricar artículos de carbono densificados mediante impresión tridimensional
KR20240039186A (ko) 2015-06-03 2024-03-26 트리아스텍 인코포레이티드 제형 및 이의 용도
CN113171350B (zh) * 2015-06-03 2023-05-26 南京三迭纪医药科技有限公司 药品剂型及其使用
US20180214383A1 (en) * 2015-07-16 2018-08-02 National University Of Singapore Printing drug tablets with fully customizable release profiles for personalized medicine
CN116423825A (zh) 2015-08-21 2023-07-14 阿普雷奇亚制药有限责任公司 三维打印系统和设备组件
GB201519128D0 (en) * 2015-10-29 2015-12-16 Univ Central Lancashire Solid forms and methods of preparing the same
AU2017261372B2 (en) 2016-05-05 2019-02-14 Triastek, Inc. Controlled release dosage form
US12303603B2 (en) * 2016-06-20 2025-05-20 Sciperio, Inc Real-time compounding 3D printer
US10765658B2 (en) 2016-06-22 2020-09-08 Mastix LLC Oral compositions delivering therapeutically effective amounts of cannabinoids
GB201612853D0 (en) 2016-07-25 2016-09-07 Univ Central Lancashire Solid dosage form production
EP3321002A1 (de) * 2016-11-15 2018-05-16 Höganäs AB Ausgangsmaterial für generatives fertigungsverfahren, generatives fertigungsverfahren damit und daraus erhaltener artikel
DE102017200773A1 (de) * 2017-01-18 2018-07-19 Eos Gmbh Electro Optical Systems Verfahren zum Nachbehandeln und Nachbehandlungssytem
KR20190107712A (ko) * 2017-01-26 2019-09-20 트리아스텍 인코포레이티드 특정 위장 부위에서의 제어 방출의 투여 형태
US10369557B2 (en) * 2017-04-12 2019-08-06 International Business Machines Corporation Three-dimensional printed objects for chemical reaction control
WO2018199998A1 (en) * 2017-04-28 2018-11-01 Hewlett-Packard Development Company, L.P. Producing diffusion-controlled release devices
WO2019025869A1 (en) * 2017-07-31 2019-02-07 Teva Pharmaceutical Industries Limited GALENIC FORMS WITH CONTROLLED RELEASE MANUFACTURED IN ADDITIVE MANNER
US11642841B2 (en) 2017-10-13 2023-05-09 Ut-Battelle, Llc Indirect additive manufacturing process
US10350822B1 (en) 2018-01-09 2019-07-16 Triastek Inc. Dosage forms with desired release profiles and methods of designing and making thereof
WO2019137200A1 (en) 2018-01-09 2019-07-18 Triastek, Inc. Oral drug dosage forms comprising a fixed-dose of an adhd non-stimulant and an adhd stimulant
EP3768378B1 (de) 2018-03-22 2025-08-06 InCarda Therapeutics, Inc. Neuartiges verfahren zur verlangsamung der ventrikulären rate
DE102018107585B3 (de) * 2018-03-29 2019-03-28 Universität Rostock Vorrichtung zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen mit Wirkstoffdepots, sowie Verfahren zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen
WO2019199328A1 (en) * 2018-04-13 2019-10-17 Hewlett-Packard Development Company, L.P. Three-dimensional printing
CN108939162B (zh) * 2018-07-10 2021-11-19 上海理工大学 一种介孔生物玻璃/海藻酸钠-海藻酸钠分层骨组织工程支架的制备方法
GB201813186D0 (en) 2018-08-13 2018-09-26 Univ Central Lancashire Solid dosage from production
CA3112618A1 (en) * 2018-09-14 2020-03-19 Merck Patent Gmbh Process for the preparation of a coated solid pharmaceutical dosage form
CA3115574A1 (en) 2018-10-15 2020-04-23 Aprecia Pharmaceuticals LLC Method and system for forming a dosage form within a packaging
US11254617B2 (en) 2019-01-09 2022-02-22 Ut-Battelle, Llc Indirect additive manufacturing process using amine-containing adhesive polymers
US12103229B2 (en) * 2019-03-15 2024-10-01 Ricoh Company, Ltd. Jettable temporary binders to create removable support materials
US11724486B2 (en) 2019-07-09 2023-08-15 Kyndryl, Inc. Printing customized medication based on current user data and medical records of the user
CA3150809A1 (en) * 2019-08-14 2021-02-18 Merck Patent Gmbh Method for additive manufacture of a product, manufacturing device and solid pharmaceutical dosage form
GB201913972D0 (en) 2019-09-27 2019-11-13 Univ Ulster Pharmaceutical Delivery Device and method of manufacture
ES2828509B2 (es) 2019-11-26 2022-03-09 Fund Idonial Composicion para la impresion 3d de farmacos semisolidos
EP3871859A1 (de) * 2020-02-26 2021-09-01 Hewlett-Packard Development Company, L.P. Dreidimensionales drucken
WO2021176360A1 (en) * 2020-03-02 2021-09-10 Craft Health Pte Ltd Oral dosage forms for extended drug release
CA3178260A1 (en) 2020-05-13 2021-11-18 Massachusetts Institute Of Technology Compositions of polymeric microdevices and their use in cancer immunotherapy
CN116018131A (zh) 2020-06-26 2023-04-25 阿普雷奇亚制药有限责任公司 具有内腔的快速口腔分散片剂
KR20230098628A (ko) 2020-10-30 2023-07-04 트리아스텍 인코포레이티드 위장관 약학적 제형
US12251208B2 (en) 2020-11-30 2025-03-18 International Business Machines Corporation Time controlled medication
KR102723494B1 (ko) * 2020-12-24 2024-10-31 동아제약 주식회사 적층 방식으로 제조된 방출 조절용 약제학적 조성물
CN112940690B (zh) * 2021-02-05 2021-11-02 中国科学院苏州纳米技术与纳米仿生研究所南昌研究院 一种具有豆荚结构的相变储能材料及其制备方法与应用
WO2024108084A1 (en) * 2022-11-18 2024-05-23 Aprecia Pharmaceuticals LLC Functionally-dividable orodispersive dosage form

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US948297A (en) * 1909-07-24 1910-02-01 John A Stone Corn-husker.
US986148A (en) * 1910-05-09 1911-03-07 Hoechst Ag Derivative of oxyarylarsinic acids and process of making same.
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
WO1985003436A1 (en) * 1984-02-10 1985-08-15 A/S Alfred Benzon Diffusion coated multiple-units dosage form
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5204055A (en) * 1989-12-08 1993-04-20 Massachusetts Institute Of Technology Three-dimensional printing techniques
NZ286242A (en) * 1991-03-26 1997-11-24 Csl Ltd Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient
US5490882A (en) * 1992-11-30 1996-02-13 Massachusetts Institute Of Technology Process for removing loose powder particles from interior passages of a body
US5775402A (en) * 1995-10-31 1998-07-07 Massachusetts Institute Of Technology Enhancement of thermal properties of tooling made by solid free form fabrication techniques
US5490962A (en) * 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
US6280771B1 (en) * 1997-02-20 2001-08-28 Therics, Inc. Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof
DE69732983T2 (de) * 1996-09-13 2006-02-16 Shionogi & Co., Ltd. Zubereitung mit verlängerter freisetzung unter verwendung einer thermischen umwandlung sowie verfahren zu deren herstellung
ATE421318T1 (de) * 1997-02-20 2009-02-15 Massachusetts Inst Technology Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
US6213168B1 (en) * 1997-03-31 2001-04-10 Therics, Inc. Apparatus and method for dispensing of powders
US5934343A (en) * 1997-03-31 1999-08-10 Therics, Inc Method for dispensing of powders
US6547994B1 (en) * 1998-11-13 2003-04-15 Therics, Inc. Rapid prototyping and manufacturing process
US6485746B1 (en) * 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
DE10015479A1 (de) * 2000-03-29 2001-10-11 Basf Ag Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
WO2001087272A2 (en) * 2000-05-18 2001-11-22 Therics, Inc. Encapsulating a toxic core within a non-toxic region in an oral dosage form
EP1370365A2 (de) * 2000-11-10 2003-12-17 Therics, Inc. Benetzungsbeständige düse zum austragen kleiner volumen flüssigkeit und ein verfahren zur herstellung einer solchen düse
DE60323482D1 (de) 2002-05-06 2008-10-23 Massachusetts Inst Technology Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken
US20050015728A1 (en) * 2003-07-17 2005-01-20 International Business Machines Corporation Method, system, and program product for customizing a user interface

Also Published As

Publication number Publication date
EP1503741A2 (de) 2005-02-09
JP5041663B2 (ja) 2012-10-03
AU2003232078A1 (en) 2003-11-17
JP2005524702A (ja) 2005-08-18
WO2003092633A3 (en) 2004-04-08
DE60323482D1 (de) 2008-10-23
ES2316791T3 (es) 2009-04-16
CA2483028C (en) 2011-04-05
US20120177696A1 (en) 2012-07-12
CA2483028A1 (en) 2003-11-13
US20040005360A1 (en) 2004-01-08
WO2003092633A2 (en) 2003-11-13
US8465777B2 (en) 2013-06-18
EP1503741B1 (de) 2008-09-10
US8088415B2 (en) 2012-01-03

Similar Documents

Publication Publication Date Title
ATE407665T1 (de) Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken
SG152240A1 (en) Pharmaceutical compositions comprising an amphiphilic starch
MX348282B (es) Formulaciones farmaceuticas de liberacion controlada de nitazoxanida.
TW200716646A (en) (S)-N-methylnaltrexone
WO2003084539A3 (en) New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
TNSN08284A1 (en) Masking the taste of powders
PL375153A1 (en) Medicinal composition for regulating release and process for producing the same
WO2005115530A3 (en) Seizure therapy method and apparatus
MX2008000099A (es) Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones.
WO2008042042A3 (en) Method and material to form a cast
UA90048C2 (ru) Кондиционированная композиция и способ ее получения
BR0210855A (pt) Método de fabricação de formulações de liberação prolongada
WO2004062577A3 (en) Two or more enteric materials to regulate drug release
MX2008011978A (es) Tratamiento del cancer de seno negativo al triple receptor.
MX2010002498A (es) Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol.
IL195294A (en) A process for the manufacture of high purity spinamide or relapinamide, their use in the preparation of medicaments and medicinal preparations containing them
DE502004005154D1 (de) Multipartikuläre arzneiform, enthaltend mucoadhaesiv formulierte peptid- oder protein-wirkstoffe, sowie ein verfahren zur herstellung der arzneiform
NO20071044L (no) Doseformer med enteraltbelagte tablettkjerner
SE0103211D0 (sv) New formulations and use thereof
TW200738228A (en) Neramexane modified release matrix tablet
DE60211769D1 (de) Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
IL250852B (en) Periodontal preparation
ECSP045232A (es) Forma de dosificación oral, procedimiento para prepararla y uso de una base débil farmacéuticamente aceptable o una sal o solvato farmacéuticamente aceptable de la misma para preparar dicha forma de dosificación oral
GB2408978B (en) Methods of preparing delta-9 tetrahydrocannabinol from plant material

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties